Literature DB >> 1461851

Intracerebral haemorrhage after thrombolytic therapy for acute myocardial infarction.

R S More1, R Vincent.   

Abstract

Seven cases of intracerebral haemorrhage were identified following the use of thrombolytic therapy in a total of 710 patients with acute myocardial infarction. Each case was reviewed in detail with particular attention to the presenting symptoms. A confusional state was the commonest initial feature. Increased age and male sex were associated with increased risk of cerebral bleed. The possible role of intravenous heparin in increasing risk and the management of affected cases is discussed. Early recognition and action is emphasized.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461851      PMCID: PMC2399515          DOI: 10.1136/pgmj.68.804.800

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Coronary thrombolysis: round two and beyond.

Authors:  R G Wilcox
Journal:  Br Heart J       Date:  1991-04

2.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

Review 3.  Basis of antifibrinolytic therapy.

Authors:  C R Prentice
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

4.  Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group.

Authors: 
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.